Open reading frames associated with cancer in the dark matter of the human genome

Cancer Genomics and Proteomics

Volumn 11, Issue 4, 2014, Pages 201-213

  Delgado, Ana Paula ^a   Brandao, Pamela ^a   Chapado, Maria Julia ^a   Hamid, Sheilin ^a   Narayanan, Ramaswamy ^a  

^a FLORIDA ATLANTIC UNIVERSITY   (United States)

Author keywords

Batch analysis; Biomarkers; Cancer association; Druggable proteome; Expression quantitative trait loci; Genome wide association; Landscape of diseases; Open reading frames; Phenome genome; Uncharacterized proteins

Indexed keywords

ARTICLE; GENE ONTOLOGY; GENETIC ASSOCIATION; HUMAN; HUMAN GENOME; NEOPLASM; OPEN READING FRAME; PROTEIN EXPRESSION; QUANTITATIVE TRAIT LOCUS; BIOLOGY; FEMALE; GENETIC DATABASE; GENETICS; GENOMICS; MALE; METABOLISM; MOLECULAR GENETICS; MUTATION; PROTEIN MOTIF; PROTEOMICS; QUANTITATIVE TRAIT;

AMINO ACID MOTIFS; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; FEMALE; GENETIC ASSOCIATION STUDIES; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMANS; MALE; MOLECULAR SEQUENCE ANNOTATION; MUTATION; NEOPLASMS; OPEN READING FRAMES; PROTEOMICS; QUANTITATIVE TRAIT LOCI; QUANTITATIVE TRAIT, HERITABLE;

EID: 84920508551     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (94)

1. Hopkins AL and Groom CR:The druggable genome. Nature reviews Drug discovery 1(9): 727-730, 2002.
2. Russ AP and Lampel S: The druggable genome: an update. Drug discovery today 10(23-24): 1607-1610, 2005.
3. Pertea M and Salzberg SL: Between a chicken and a grape: estimating the number of human genes. Genome biology 11(5): 206, 2010.
4. Martin L, and Chang HY: Uncovering the role of genomic "dark matter" in human disease. The Journal of clinical investigation 122(5): 1589-1595, 2012.
5. Griffith M, Griffith OL, Coffman AC, Weible JV, McMichael JF, Spies NC et al: DGIdb: mining the druggable genome. Nature methods 10(12): 1209-1210, 2013.
6. Rask-Andersen M, Almen MS and Schioth HB: Trends in the exploitation of novel drug targets. Nature reviews Drug discovery 10(8): 579-590, 2011.
7. Blaxter M: Genetics. Revealing the dark matter of the genome. Science 330(6012): 1758-1759, 2010.
8. Nadzirin N and Firdaus-Raih M: Proteins of Unknown Function in the Protein Data Bank (PDB): An Inventory of True Uncharacterized Proteins and Computational Tools for Their Analysis. International journal of molecular sciences 13(10): 12761-12772, 2012.
9. Brylinski M: Exploring the "dark matter" of a mammalian proteome by protein structure and function modeling. Proteome science 11(1): 47, 2013.
10. Delgado A, Brandao P, Hamid S and Narayanan R: Mining the Dark Matter of the Cancer Proteome for novel biomarkers. Current Cancer Therapy Reviews 9(4): 265-277, 2013.
11. Delgado AP, Hamid S, Brandao P and Narayanan R: A novel transmembrane glycoprotein cancer biomarker present in the x chromosome. Cancer genomics & proteomics 11(2): 81-92, 2014.
12. Zhang Y, De S, Garner JR, Smith K, Wang SA and Becker KG: Systematic analysis, comparison, and integration of disease based human genetic association data and mouse genetic phenotypic information. BMC medical genomics 1, 2010.
13. Ramos EM, Hoffman D, Junkins HA, Maglott D, Phan L, Sherry ST et al: Phenotype-Genotype Integrator (PheGenI): synthesizing genome-wide association study (GWAS) data with existing genomic resources. Eur J Hum Genet 22(1): 144-147, 2014.
14. Halling-Brown MD, Bulusu KC, Patel M, Tym JE and Al- Lazikani B: canSAR: an integrated cancer public translational research and drug discovery resource. Nucleic acids research 40(Database issue): D947-56, 2012.
15. Kolker E, Higdon R, Haynes W, Welch D, Broomall W, Lancet D et al: MOPED: Model Organism Protein Expression Database. Nucleic acids research 40(Database issue): D1093-9, 2012.
16. Keshava Prasad TS, Goel R, Kandasamy K, Keerthikumar S, Kumar S, Mathivanan S et al: Human Protein Reference Database-2009 update. Nucleic acids research 37(Database issue): D767-72, 2009.
17. Safran M, Dalah I, Alexander J, Rosen N, Iny Stein T, Shmoish M et al: GeneCards Version 3: the human gene integrator. Database 2010.
18. Huang DW, Sherman BT and Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protocols 4(1):44-57, 2008.
19. Uhlen M, Oksvold P, Fagerberg L, Lundberg E, Jonasson K, Forsberg M et al: Towards a knowledge-based Human Protein Atlas. Nature biotechnology 28(12): 1248-1250, 2010.
20. MacDonald JR, Ziman R, Yuen RK, Feuk L and Scherer SW: The Database of Genomic Variants: a curated collection of structural variation in the human genome. Nucleic acids research 42(Database issue): D986-992, 2014.
21. Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM et al: ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic acids research 42(Database issue): D980-985, 2014.
22. Becker KG, Barnes KC, Bright TJ and Wang SA: The genetic association database. Nature genetics 36(5): 431-432, 2004.
23. Wang LD, Zhou FY, Li XM, Sun LD, Song X, Jin Y et al: Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nature genetics 42(9): 759-763, 2010.
24. Mulder NJ, Apweiler R, Attwood TK, Bairoch A, Bateman A, Binns D et al: InterPro: an integrated documentation resource for protein families, domains and functional sites. Briefings in bioinformatics 3(3): 225-235, 2002.
25. Marchler-Bauer A, Zheng C, Chitsaz F, Derbyshire MK, Geer LY, Geer RC et al: CDD: conserved domains and protein threedimensional structure. Nucleic acids research 41(Database issue): D348-52, 2013.
26. Punta M, Coggill PC, Eberhardt RY, Mistry J, Tate J, Boursnell C et al: The Pfam protein families database. Nucleic acids research 40(Database issue): D290-301, 2012.
27. Finn RD, Bateman A, Clements J, Coggill P, Eberhardt RY, Eddy SR et al: Pfam: the protein families database. Nucleic acids research 42(D1): D222-D30, 2014.
28. Finn RD, Clements J and Eddy SR: HMMER web server: interactive sequence similarity searching. Nucleic acids research 39(Web Server issue): W29-37, 2011.
29. Servant F, Bru C, Carrere S, Courcelle E, Gouzy J, Peyruc D et al: ProDom: automated clustering of homologous domains. Briefings in bioinformatics 3(3): 246-51, 2002.
30. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM et al: The human genome browser at UCSC. Genome research 12(6): 996-1006, 2002.
31. Petersen TN, Brunak S, von Heijne G and Nielsen H: SignalP 4.0: discriminating signal peptides from transmembrane regions. Nature methods 8(10): 785-786, 2011.
32. Liang L, Morar N, Dixon AL, Lathrop GM, Abecasis GR, Moffatt MF et al: A cross-platform analysis of 14,177 expression quantitative trait loci derived from lymphoblastoid cell lines. Genome research 23(4): 716-726, 2013.
33. Stranger BE, Montgomery SB, Dimas AS, Parts L, Stegle O, Ingle CE et al: Patterns of cis regulatory variation in diverse human populations. PLoS genetics 8(4): e1002639, 2012.
34. Consortium GT: The Genotype-Tissue Expression (GTEx) project. Nature genetics 45(6): 580-585, 2013.
35. Tenesa A, Farrington SM, Prendergast JG, Porteous ME, Walker M, Haq N et al: Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nature genetics 40(5): 631-637, 2008.
36. Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, Beare D et al: COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic acids research 39(Database issue): D945-50, 2011.
37. Wagle N, Van Allen EM, Treacy DJ, Frederick DT, Cooper ZA, Taylor-Weiner A et al: MAP kinase pathway alterations in BRAFmutant melanoma patients with acquired resistance to combined RAF/MEK inhibition. Cancer discovery 4(1): 61-68, 2014.
38. Pugh TJ, Morozova O, Attiyeh EF, Asgharzadeh S, Wei JS, Auclair D et al: The genetic landscape of high-risk neuroblastoma. Nature genetics 45(3): 279-284, 2013.
39. Cancer Genome Atlas N: Comprehensive molecular characterization of human colon and rectal cancer. Nature 487(7407): 330-337, 2012.
40. Seshagiri S, Stawiski EW, Durinck S, Modrusan Z, Storm EE, Conboy CB et al: Recurrent R-spondin fusions in colon cancer. Nature 488(7413): 660-664, 2012.
41. Cancer Genome Atlas Research N: Integrated genomic analyses of ovarian carcinoma. Nature 474(7353): 609-615, 2011.
42. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA et al: The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer discovery 2(5): 401-404, 2012.
43. Gronskov K, Dooley CM, Ostergaard E, Kelsh RN, Hansen L, Levesque MP et al: Mutations in c10orf11, a melanocytedifferentiation gene, cause autosomal-recessive albinism. American journal of human genetics 92(3): 415-421, 2013.
44. Kiyotani K, Mushiroda T, Tsunoda T, Morizono T, Hosono N, Kubo M et al: A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in Japanese. Human molecular genetics 21(7): 1665-1672, 2012.
45. Benusiglio PR, Pharoah PD, Smith PL, Lesueur F, Conroy D, Luben RN et al: HapMap-based study of the 17q21 ERBB2 amplicon in susceptibility to breast cancer. British journal of cancer 95(12): 1689-1695, 2006.
46. Mavaddat N, Dunning AM, Ponder BA, Easton DF and Pharoah PD: Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 18(1): 255-259, 2009.
47. Murabito JM, Rosenberg CL, Finger D, Kreger BE, Levy D, Splansky GL et al: A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study. BMC medical genetics 8(Suppl 1): S6, 2007.
48. Springwald A, Lattrich C, Seitz S, Ortmann O and Treeck O: Single nucleotide polymorphisms in human gene icb-1 and breast cancer susceptibility. Cancer investigation 27(6): 669-672, 2009.
49. Korn R, Rohrig S, Schulze-Kremer S and Brinkmann U: Common denominator procedure: a novel approach to geneexpression data mining for identification of phenotype-specific genes. Bioinformatics 21(11): 2766-2772, 2005.
50. Kerns SL, Ostrer H, Stock R, Li W, Moore J, Pearlman A et al: Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer. International journal of radiation oncology, biology, physics 78(5): 1292-1300, 2010.
51. Takata R, Akamatsu S, Kubo M, Takahashi A, Hosono N, Kawaguchi T et al: Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population. Nature genetics 42(9): 751-754, 2010.
52. Baker RF, Powars D and Haywood LJ: Restriction of calcium uptake in normal and sickle red cells by procaine hydrochloride and P-aminobenzoic acid. Biochemical and biophysical research communications 75(2): 381-388, 1977.
53. Eeles RA, Kote-Jarai Z, Al Olama AA, Giles GG, Guy M, Severi G et al: Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nature genetics 41(10): 1116-1121, 2009.
54. Xu J, Zheng SL, Isaacs SD, Wiley KE, Wiklund F, Sun J et al: Inherited genetic variant predisposes to aggressive but not indolent prostate cancer. Proceedings of the National Academy of Sciences of the United States of America 107(5): 2136-2140, 2010.
55. Clifford R, Edmonson M, Hu Y, Nguyen C, Scherpbier T and Buetow KH: Expression-based genetic/physical maps of singlenucleotide polymorphisms identified by the cancer genome anatomy project. Genome research 10(8): 1259-1265, 2000.
56. Gu J, Chen M, Shete S, Amos CI, Kamat A, Ye Y et al: A genome-wide association study identifies a locus on chromosome 14q21 as a predictor of leukocyte telomere length and as a marker of susceptibility for bladder cancer. Cancer prevention research 4(4): 514-521, 2011.
57. Wu C, Hu Z, He Z, Jia W, Wang F, Zhou Y et al: Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations. Nature genetics 43(7): 679-84, 2011.
58. Clague J, Lippman SM, Yang H, Hildebrandt MA, Ye Y, Lee JJ et al: Genetic variation in MicroRNA genes and risk of oral premalignant lesions. Molecular carcinogenesis 49(2): 183-189, 2010.
59. Yoon KA, Park JH, Han J, Park S, Lee GK, Han JY et al: A genome-wide association study reveals susceptibility variants for non-small cell lung cancer in the Korean population. Human molecular genetics 19(24): 4948-4954, 2010.
60. Cha PC, Zembutsu H, Takahashi A, Kubo M, Kamatani N and Nakamura Y: A genome-wide association study identifies SNP in DCC is associated with gallbladder cancer in the Japanese population. Journal of human genetics 57(4): 235-237, 2012.
61. McNeill A, Rattenberry E, Barber R, Killick P, MacDonald F and Maher ER: Genotype-phenotype correlations in VHL exon deletions. American journal of medical genetics Part A 149A(10): 2147-2151, 2009.
62. Trevino LR, Yang W, French D, Hunger SP, Carroll WL, Devidas M et al: Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nature genetics 41(9): 1001-1005, 2009.
63. Yang J, Zhao JJ, Zhu Y, Xiong W, Lin JY and Ma X: Identification of candidate cancer genes involved in human retinoblastoma by data mining. Child's nervous system: ChNS: official journal of the International Society for Pediatric Neurosurgery 24(8): 893-900, 2008.
64. Ellinghaus E, Stanulla M, Richter G, Ellinghaus D, te Kronnie G, Cario G et al: Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia. Leukemia 26(5): 902-909, 2012.
65. Kim DH, Lee ST, Won HH, Kim S, Kim MJ, Kim HJ et al: A genome-wide association study identifies novel loci associated with susceptibility to chronic myeloid leukemia. Blood 117(25): 6906-6911, 2011.
66. Pittman AM, Webb E, Carvajal-Carmona L, Howarth K, Di Bernardo MC, Broderick P et al: Refinement of the basis and impact of common 11q23.1 variation to the risk of developing colorectal cancer. Human molecular genetics 17(23): 3720-3727, 2008.
67. Yang JJ, Cheng C, Yang W, Pei D, Cao X, Fan Y et al: Genomewide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia. JAMA: the journal of the American Medical Association 301(4): 393-403, 2009.
68. Hosgood HD, 3rd, Zhang L, Shen M, Berndt SI, Vermeulen R, Li G et al: Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity. Occupational and environmental medicine 66(12): 848-853, 2009.
69. Pierce BL and Ahsan H: Genetic susceptibility to type 2 diabetes is associated with reduced prostate cancer risk. Human heredity 69(3): 193-201, 2010.
70. Bradfield JP, Qu HQ, Wang K, Zhang H, Sleiman PM, Kim CE et al: A genome-wide meta-analysis of six type 1 diabetes cohorts identifies multiple associated loci. PLoS genetics 7(9): e1002293, 2011.
71. Barcellos LF, May SL, Ramsay PP, Quach HL, Lane JA, Nititham J et al: High-density SNP screening of the major histocompatibility complex in systemic lupus erythematosus demonstrates strong evidence for independent susceptibility regions. PLoS genetics 5(10): e1000696, 2009.
72. Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C et al: Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's disease. Nature genetics 42(8): 698- 702, 2010.
73. Hom G, Graham RR, Modrek B, Taylor KE, Ortmann W, Garnier S et al: Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. The New England journal of medicine 358(9): 900-909, 2008.
74. Lindmark F, Zheng SL, Wiklund F, Bensen J, Balter KA, Chang B et al: H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer. Journal of the National Cancer Institute 96(16): 1248-1254, 2004.
75. Djaldetti M and Bessler H: Modulators affecting the immune dialogue between human immune and colon cancer cells. World journal of gastrointestinal oncology 6(5): 129-138, 2014.
76. Maru GB, Gandhi K, Ramchandani A and Kumar G: The role of inflammation in skin cancer. Advances in experimental medicine and biology 816: 437-469, 2014.
77. Bonomi M, Patsias A, Posner M and Sikora A: The role of inflammation in head and neck cancer. Advances in experimental medicine and biology 816: 107-127, 2014.
78. de Rooij J: Adhesion in vascular biology: Mechanics control dynamics. Cell adhesion & migration 8(2), 2014.
79. Murphy G: Tissue inhibitors of metalloproteinases. Genome biology 12(11): 233, 2011.
80. Postel-Vinay S, Veron AS, Tirode F, Pierron G, Reynaud S, Kovar H et al: Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma. Nature genetics 44(3): 323-7, 2012.
81. Bailey SD, Xie C, Do R, Montpetit A, Diaz R, Mohan V et al: Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study. Diabetes care 33(10): 2250-3, 2010.
82. Benjamin EJ, Dupuis J, Larson MG, Lunetta KL, Booth SL, Govindaraju DR et al: Genome-wide association with select biomarker traits in the Framingham Heart Study. BMC medical genetics 8(Suppl 1): S11, 2007.
83. Zheng W, Long J, Gao YT, Li C, Zheng Y, Xiang YB et al: Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nature genetics 41(3): 324-328, 2009.
84. Yang Q, Kathiresan S, Lin JP, Tofler GH and O'Donnell CJ: Genome-wide association and linkage analyses of hemostatic factors and hematological phenotypes in the Framingham Heart Study. BMC medical genetics 8(Suppl 1): S12, 2007.
85. Bielinski SJ, Chai HS, Pathak J, Talwalkar JA, Limburg PJ, Gullerud RE et al: Mayo Genome Consortia: a genotypephenotype resource for genome-wide association studies with an application to the analysis of circulating bilirubin levels. Mayo Clinic proceedings 86(7): 606-614, 2011.
86. Han MR, Schellenberg GD and Wang LS, Alzheimer's Disease Neuroimaging I: Genome-wide association reveals genetic effects on human Abeta42 and tau protein levels in cerebrospinal fluids: a case control study. BMC neurology 10: 90, 2010.
87. Chapuis J, Hot D, Hansmannel F, Kerdraon O, Ferreira S, Hubans C et al: Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease. Molecular psychiatry 14(11): 1004-1016, 2009.
88. Gille O, Oliveira Bde A, Guerin P, Lepreux S, Richez C and Vital JM: Regression of giant cell tumor of the cervical spine with bisphosphonate as single therapy. Spine 37(6): E396-399, 2012.
89. Babcock JJ and Li M: Deorphanizing the human transmembrane genome: A landscape of uncharacterized membrane proteins. Acta pharmacologica Sinica. 2013.
90. DeYoung MP, Tress M and Narayanan R: Identification of Down's syndrome critical locus gene SIM2-s as a drug therapy target for solid tumors. Proceedings of the National Academy of Sciences of the United States of America 100(8): 4760-4765, 2003.
91. Chehval V and Norian LA: Effects of obesity on immune responses to renal tumors. Immunologic research. 2014.
92. Candelario KM and Steindler DA: The role of extracellular vesicles in the progression of neurodegenerative disease and cancer. Trends in molecular medicine. S1471-4914, 2014.
93. El-Zein M, Parent ME, Siemiatycki J and Rousseau MC: History of allergic diseases and lung cancer risk. Annals of allergy, asthma & immunology: official publication of the American College of Allergy, Asthma, & Immunology 112(3): 230-236, 2014.
94. Riondino S, Roselli M, Palmirotta R, Della-Morte D, Ferroni P and Guadagni F: Obesity and colorectal cancer: Role of adipokines in tumor initiation and progression. World journal of gastroenterology: WJG 20(18): 5177-5190, 2014.